Biotechnology Industry News | BioSpace

Vertex Scraps Two Phase I AATD Candidates Following Disappointing Data

11 months ago

Adaptimmune’s Tecelra Becomes First FDA-Approved Engineered Cell Therapy for Solid Tumors

11 months ago

GSK Wins Broad Label Expansion for Jemperli in First-Line Endometrial Cancer

11 months ago

RSV Vaccine Makers Hit Hard by New CDC Guidelines

11 months ago

GSK, Moderna and Pfizer are all looking at potential respiratory syncytial virus...

Vir Lays Off 25% of Staff, Abandons Most Virus Work and Pivots to Cancer in Sanofi Deal

11 months ago

Otsuka Pays Up to $1.1B to Buy Jnana, Adds Drug Discovery Capabilities

11 months ago

Moderna Cuts Full-Year Revenue Guidance as COVID-19 Vaccine Sales Crater in Q2

11 months ago

Moderna’s stock price plunged more than 20% in Thursday morning trading after...

California’s Jobs Outlook: Life Sciences Sector Inching Toward Recovery?

11 months ago

The Political Shape of the Future Clinical Trial Space

11 months ago

FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm

11 months ago

Sanofi Sues Sarepta Over Elevidys DMD Gene Therapy, Alleges Patent Infringement

11 months ago

Lilly’s Tirzepatide Clears Phase III Cardiovascular Study on Heels of Novo

11 months ago

Eli Lilly on Thursday released late-stage data showing a 38% reduction in...